| Literature DB >> 30355487 |
Massimiliano Clamer1, Toma Tebaldi2, Fabio Lauria3, Paola Bernabò3, Rodolfo F Gómez-Biagi4, Marta Marchioretto3, Divya T Kandala5, Luca Minati5, Elena Perenthaler3, Daniele Gubert6, Laura Pasquardini4, Graziano Guella7, Ewout J N Groen8, Thomas H Gillingwater8, Alessandro Quattrone2, Gabriella Viero9.
Abstract
Ribosome profiling, or Ribo-seq, is based on large-scale sequencing of RNA fragments protected from nuclease digestion by ribosomes. Thanks to its unique ability to provide positional information about ribosomes flowing along transcripts, this method can be used to shed light on mechanistic aspects of translation. However, current Ribo-seq approaches lack the ability to distinguish between fragments protected by either ribosomes in active translation or inactive ribosomes. To overcome this possible limitation, we developed RiboLace, a method based on an original puromycin-containing molecule capable of isolating active ribosomes by means of an antibody-free and tag-free pull-down approach. RiboLace is fast, works reliably with low amounts of input material, and can be easily and rapidly applied both in vitro and in vivo, thereby generating a global snapshot of active ribosome footprints at single nucleotide resolution.Entities:
Keywords: polysomal profiling; protein synthesis; proteome; puromycin; ribosome; ribosome profiling; translation; translational control; translatome
Mesh:
Substances:
Year: 2018 PMID: 30355487 DOI: 10.1016/j.celrep.2018.09.084
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423